Prof. CHEZY BARENHOLZ
Current approaches for the treatment to prevent COVID-19
Department of Biochemistry and Molecular Biology.
The Hebrew University of Jerusalem.
Prof. Barenholz is the developer of DOXIL, a medicine approved for human use in the USA in 1996 and in Europe in 1997.
It is extensively used to treat ovarian cancer and breast cancer.
